@ARTICLE{10.3389/fnmol.2019.00001, AUTHOR={Zhuo, Chuanjun and Wang, Dawei and Zhou, Chunhua and Chen, Ce and Li, Jie and Tian, Hongjun and Li, Shen and Ji, Feng and Liu, Chuanxin and Chen, Min and Zhang, Li}, TITLE={Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia}, JOURNAL={Frontiers in Molecular Neuroscience}, VOLUME={12}, YEAR={2019}, URL={https://www.frontiersin.org/articles/10.3389/fnmol.2019.00001}, DOI={10.3389/fnmol.2019.00001}, ISSN={1662-5099}, ABSTRACT={Schizophrenia (SCZ) is a common psychiatric disorder with polygenetic pathogenesis. Among the many identified candidate genes and loci, the group of tumour suppressor genes has drawn our interest. In this mini-review article, we describe evidence of a correlation between major tumour suppressor genes and SCZ development. Genetic mutations ranging from single nucleotide polymorphisms to large structural alterations have been found in tumour-related genes in patients with SCZ. Epigenetic mechanisms, including DNA methylation/acetylation and microRNA regulation of tumour suppressor genes, have also been implicated in SCZ. Beyond genetic correlations, we hope to establish causal relationships between tumour suppressor gene function and SCZ risk. Accumulating evidence shows that tumour suppressor genes may mediate cell survival and neural development, both of which contribute to SCZ aetiology. Moreover, converging intracellular signalling pathways indicate a role of tumour suppressor genes in SCZ pathogenesis. Tumour suppressor gene function may mediate a direct link between neural development and function and psychiatric disorders, including SCZ. A deeper understanding of how neural cell development is affected by tumour suppressors may lead to improved anti-psychotic drugs.} }